Related content

Letter to the Editor: Combined CYP2C9, VKORC1 and CYP4F2 frequencies among Amerindians, Mozambicans and Brazilians

By Vargens Daniela D   Damasceno Albertino   Petzl-Erler Maria-Luiza   Suarez-Kurtz Guilherme  

Pharmacogenomics, Vol. 12, Iss. 6, 2011-06 ,pp. : 769-772

Future Medicine

Access to resources Recommend Favorite

VKORC1, CYP2C9 and CYP4F2 genetic-based algorithm for warfarin dosing: an Italian retrospective study

By Zambon Carlo-Federico   Pengo Vittorio   Padrini Roberto   Basso Daniela   Schiavon Stefania   Fogar Paola   Nisi Alessandra   Frigo Anna Chiara   Moz Stefania   Pelloso Michela   Plebani Mario  

Pharmacogenomics, Vol. 12, Iss. 1, 2011-01 ,pp. : 15-25

Future Medicine

Access to resources Recommend Favorite

Copy number variation and warfarin dosing: evaluation of CYP2C9, VKORC1, CYP4F2, GGCX and CALU

By Scott Stuart A   Patel Manishkumar   Martis Suparna   Lubitz Steven A   van der Zee Sarina   Yoo Chang   Edelmann Lisa   Halperin Jonathan L   Desnick Robert J  

Pharmacogenomics, Vol. 13, Iss. 3, 2012-02 ,pp. : 297-307

Future Medicine

Access to resources Recommend Favorite

Dosing algorithm for warfarin using CYP2C9 and VKORC1 genotyping from a multi-ethnic population: comparison with other equations

By Wu Alan HB   Wang Ping   Smith Andrew   Haller Christine   Drake Katherine   Linder Mark   Valdes Roland  

Pharmacogenomics, Vol. 9, Iss. 2, 2008-02 ,pp. : 169-178

Future Medicine

Access to resources Recommend Favorite

Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European––Americans and African––Americans

By Limdi Nita A   Arnett Donna K   Goldstein Joyce A   Beasley T Mark   McGwin Gerald   Adler Brian K   Acton Ronald T  

Pharmacogenomics, Vol. 9, Iss. 5, 2008-05 ,pp. : 511-526

Future Medicine

Access to resources Recommend Favorite